Two studies presented at SABCS offer a better understanding of what to do with the information sentinel lymph nodes provide. When breast cancer spreads, it often appears first in the sentinel node—the ...

Sentinel lymph node biopsy (SLNB) is critical to breast cancer staging, yet current assessment methods remain heavily ...

University of Queensland researchers have received a $3.1 million grant for a trial which could revolutionize endometrial cancer treatment. Research Director Professor Andreas Obermair at UQ's ...

Lymphatic mapping, a recent technique first developed for the management of melanoma, is based on the concept that information about the status of the entire lymphatic drainage from a tumor site could ...

Lymph nodes are small organs, typically ranging from the size of a pea to a little bean, which are located throughout the body. Lymph nodes are one of the components of the lymphatic system. There are ...

Advances in cancer treatment mean more people are living longer after a cancer diagnosis. But some survivors develop lymphedema—long-term swelling in the arms, hands, legs or feet that can cause pain, ...

For women who have breast cancer, doctors usually remove 10 to 20 lymph nodes from under the arm in order to find out if it as spread. That procedure can cause numbness, loss of range of motion and ...

Preoperative 3-dimensional visualization of sentinel lymph nodes (SLNs) with a technique known as single-photon emission computed tomography/computed tomography was associated with a higher rate of ...

Biopsies of so-called "sentinel" lymph nodes under the arms should become more widespread among breast cancer patients, according to updated guidelines from the American Society of Clinical Oncology ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving wide local excision or Mohs micrographic surgery showed similar survival outcomes (HR = 1.04) ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...